Fzata
WebFind company research, competitor information, contact details & financial data for Fzata Inc of Halethorpe, MD. Get the latest business insights from Dun & Bradstreet.
Fzata
Did you know?
WebFzata, Inc. is a near-clinical stage biopharma company developing needle free biologics for gastrointestinal (GI) -related diseases/disorders , incl. gut-axis disorders. Fzata has a deep pipeline for infectious, inflammatory and metabolic diseases. WebFZata is a prclinical biotherapeutics company. Our vision is to expand patient access to therapeutic biologics by replacing the needle with an oral capsule of yeast therapeutic … Zhiyong Yang PhD, Co-founder and CEO of Fzata, Inc. Dr. Yang received her PhD … The Fzata BioPYM platform can make biotherapeutics including antibodies, … Fzata's preclinical pipeline contains oral yeast drug candidates that make … Fzata is pleased to announce that our lead drug, FZ002, has advanced to … Contact information for reaching a Fzata executive for development, partnering or …
WebJan 26, 2024 · HALETHORPE, Md., Jan. 26, 2024 /PRNewswire/ -- Fzata, Inc., announces that it is raising series A funding for its first-in-class Bioengineered Probiotic Yeast Medicines (BioPYM™) platform.This is a novel oral administration modality for biologics. Fzata's vision is to replace needle administration of biologics with a capsule for suffers of … WebFZata, Inc. is an antibody technology company dedicated to developing antibody-based therapeutic and preventive medicines. Our strategy is to utilize the power of human immunity of antibodies for applications against diseases. Our mission is to create innovative me dicines that make a real difference to health.
WebFZata corporate office is located in 1448 S Rolling Rd Ste 120, Halethorpe, Maryland, 21227, United States and has 9 employees. fzata inc. fzata inc. fzata. fzata. fzata inc. FZata Global Presence. Location: People at location: North America: 9: Search All Employees. FZata CEO. Zhiyong Yang Chief Executive Officer. Phone Email. WebFZata is a pre-clinical stage biotech company with a focus on developing antibody-based therapeutics with our proprietary platforms (Humanized Tetrabody platform; Yeast Biotherapy Platform). FZata has generated a pipeline targeting at gastrointestinal related infectious, inflammatory and metabolic diseases.
WebDec 20, 2024 · Event: Biotech Showcase™ 2024, January 9-11, 2024 (San Francisco, CA). Fzata will pitch live Wednesday, January 11 at 4:15, Room Franciscan B, Hilton San …
WebI'm starting to lose regular customers to other contractors who have online capabilities. Fazta will keep my operation competitive. felix blake agents of shieldWebFZata, Inc. is an antibody technology company dedicated to developing antibody-based therapeutic and preventive medicines. Our strategy is to utilize the power of human … felix blackwell - stolen tonguesWebFzata is honored to have won the Mid-Atlantic Biotechnology Innovation Award! Shared by Zhiyong Yang Fzata has been selected as a 2024 Mid-Atlantic Innovation Celebration … felix bloch state departmentWebJul 18, 2024 · CEOCFO: Fzata is working on something for diabetes as well. Tell us about that if you would? Dr. Yang: Yes, one of the products in our pipeline, FZ010, is targeting … felix blender in his headWebJan 26, 2024 · Fzata, Inc., announces that it is raising series A funding for its first-in-class Bioengineered Probiotic Yeast Medicines (BioPYM™) platform. This is a novel oral … felix blackwell black toyotaWebThe online consultation assumed essentially the same form in the Assembly website as had that of the pilot project on the FTZA.An introductory page outlined the committee's terms … felix blue cheeseWebDec 20, 2024 · About Fzata, Inc.: Fzata (www.Fzata.com) is a near-clinical stage biopharmaceutical company, developing oral live biologic-based preventive and … felix bites ear